GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test PR Newswire MENLO PARK...
PR Newswire
GRAIL Reports Second Quarter 2026 Financial Results
GRAIL Reports Second Quarter 2026 Financial Results GRAIL Reports Second Quarter 2026 Financial Results PR Newswire MENLO PARK, Calif., Aug. 5, 2026 Q2 Galleri Test Volume Increased 35% to More Than 61,000 Year-Over-Year, and Galleri Revenue Grew 24% to $42.6 Million Galleri Test Volume and Revenue...
PR Newswire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. (Grail or the Company) (NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed...
Business Wire
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm PR Newswire...
PR Newswire
GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire SAN FRANCISCO, Aug. 4, 2026 SAN FRANCISCO, Aug. 4, 2026...
PR Newswire
Jazz Pharmaceuticals (JAZZ) Q2 Earnings Lag Estimates
Jazz (JAZZ) delivered earnings and revenue surprises of -5.46% and +9.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
GRAIL, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRAL
GRAIL, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRAL GRAIL, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRAL PR Newswire LOS ANGELES, Aug. 3, 2026 LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS...
PR Newswire
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman...
PR Newswire
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with SBS Law
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with SBS Law GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with SBS Law PR Newswire LOS ANGELES, July 31, 2026 LOS ANGELES, July 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP("SBS...
PR Newswire
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference PR Newswire MENLO PARK, Calif., July 30, 2026 MENLO PARK, Calif., July 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose...
PR Newswire